Regaloside E is primarily studied for its potential anti-inflammatory and immunomodulatory effects. It has shown activity in inhibiting pro-inflammatory cytokines, making it a candidate for research in chronic inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, Regaloside E exhibits antioxidant properties, which may contribute to cellular protection against oxidative stress, a factor in aging and neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Preliminary studies suggest it may also have antitumor potential by inducing apoptosis in certain cancer cell lines, particularly in liver and breast cancer models. Due to its natural origin and bioactivity, it is being explored as a lead compound for developing nutraceuticals and phytopharmaceuticals aimed at supporting immune health and preventing inflammation-related conditions.